Published: 14 May 2020
Author(s): Giuseppe Boriani, Menno V. Huisman, Christine Teutsch, Sabrina Marler, Lionel Riou França, Shihai Lu, Gregory Y.H. Lip, GLORIA-AF Investigators

Body mass index (BMI) is widely used for estimating adiposity and has been extensively studied across different populations for evaluating the relationships between BMI values and the risks of specific diseases, as well as with the risk of death [1]. Since atrial fibrillation (AF) is a common arrhythmia, the relationship between BMI and AF has received much attention, mainly focusing on the risk of AF in obesity [2] or on the long term outcome of AF patients stratified by different BMI classes included in randomized controlled trials, in most cases targeted to evaluate the effect on stroke and thromboembolism of oral anticoagulants (OACs) [3–6].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.